Nyxoid 1,8 mg, Nasenspray

7680669300012 CH-66930 Nasenspray

Associated product:

Nyxoid 1,8 mg, Nasenspray
Nyxoid 1,8 mg, Nasenspray
Nyxoid 1,8 mg, Nasenspray
Nyxoid 1,8 mg, Nasenspray
1 / 3
google

Article details

Package size
2
Selling units
2
Measure
Einzeldose(n)
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/05/2025
Patient information leaflet
Français
16/05/2025
Patient information leaflet
Italien
16/05/2025
Summary of Product Characteristics
Allemand
16/05/2025
Summary of Product Characteristics
Français
16/05/2025
Summary of Product Characteristics
Italien
16/05/2025

Detailed composition

Substance Quantity Type Category
naloxoni hydrochloridum dihydricum
2.2 MG Substance WIZUS
naloxoni hydrochloridum anhydricum
2.0 MG Substance WIZUS
naloxonum
1.8 MG Substance Wirkstoff (Principe actif)
trinatrii citras dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
acidum hydrochloridum concentratum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
nitrogenia
- Substance TRGAS
aqua purificata
- Substance HNIDK
natrium
0.14 MG Substance HBESI

Authorization holder

Mundipharma Medical Company,

4052 Basel

Authorization information

Swissmedic authorization number
66930
Drug name
Nyxoid, Nasenspray
Galenic form
NASS
ATC Code
V03AB15
Authorization status
Z
Dispensing category
B
First authorization
12/07/2018
Authorization expiration date
31/12/9999
IT Number
15.01.1.
Domain
Human medicine
Field of application
Opioid-Antagonist

Package details

Description (FR)
NYXOID spray nasal 1.8 mg 2 x 1 dos
Description (DE)
NYXOID Nasenspray 1.8 mg 2 x 1 Dos
Narcotic (BTM)
No
Buy us a coffee Explore the data